Ms. Christo brings to Constellation 25 years of product development experience in the biopharmaceutical industry. Most recently, she was Senior Vice President of Development Operations at Verastem Oncology, where she was responsible for clinical operations, data management, biostatistics, medical writing, safety, regulatory affairs, program planning and management, and translational medicine. While at Verastem, she contributed to the recent approval of COPIKTRA™. Prior to Verastem, she held positions of increasing responsibility in clinical operations and program management at X4 Pharmaceuticals, Molecular Insight Pharmaceuticals, Fresenius Biotech, Taris Biomedical, and CombinatoRx. Earlier in her career she was a biostatistician at several pharmaceutical/medical device companies, notably Millennium Pharmaceuticals, where she contributed to the development and approval of VELCADE®. She holds an M.A. in statistics from Texas Tech University.